BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15385496)

  • 1. Sm14 of Schistosoma mansoni in fusion with tetanus toxin fragment C induces immunoprotection against tetanus and schistosomiasis in mice.
    Abreu PA; Miyasato PA; Vilar MM; Dias WO; Ho PL; Tendler M; Nascimento AL
    Infect Immun; 2004 Oct; 72(10):5931-7. PubMed ID: 15385496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.
    Varaldo PB; Leite LC; Dias WO; Miyaji EN; Torres FI; Gebara VC; Armôa GR; Campos AS; Matos DC; Winter N; Gicquel B; Vilar MM; McFadden J; Almeida MS; Tendler M; McIntosh D
    Infect Immun; 2004 Jun; 72(6):3336-43. PubMed ID: 15155638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterial codon optimization of the gene encoding the Sm14 antigen of Schistosoma mansoni in recombinant Mycobacterium bovis Bacille Calmette-Guérin enhances protein expression but not protection against cercarial challenge in mice.
    Varaldo PB; Miyaji EN; Vilar MM; Campos AS; Dias WO; Armôa GR; Tendler M; Leite LC; McIntosh D
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):132-9. PubMed ID: 16965361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T cell epitope mapping of the Schistosoma mansoni 14-kDa fatty acid-binding protein using cells from patients living in areas endemic for schistosomiasis.
    Fonseca CT; Cunha-Neto E; Goldberg AC; Kalil J; de Jesus AR; Carvalho EM; Correa-Oliveira R; Oliveira SC
    Microbes Infect; 2005 Feb; 7(2):204-12. PubMed ID: 15725385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.
    Medaglini D; Ciabattini A; Spinosa MR; Maggi T; Marcotte H; Oggioni MR; Pozzi G
    Vaccine; 2001 Feb; 19(15-16):1931-9. PubMed ID: 11228363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone.
    Fonseca CT; Pacífico LG; Barsante MM; Rassi T; Cassali GD; Oliveira SC
    Microbes Infect; 2006 Aug; 8(9-10):2509-16. PubMed ID: 16914349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate.
    Ramos CR; Spisni A; Oyama S; Sforça ML; Ramos HR; Vilar MM; Alves AC; Figueredo RC; Tendler M; Zanchin NI; Pertinhez TA; Ho PL
    Biochim Biophys Acta; 2009 Apr; 1794(4):655-62. PubMed ID: 19150418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella.
    Khan CM; Villarreal-Ramos B; Pierce RJ; Riveau G; Demarco de Hormaeche R; McNeill H; Ali T; Fairweather N; Chatfield S; Capron A
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11261-5. PubMed ID: 7972044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model.
    Mossallam SF; Amer EI; Ewaisha RE; Khalil AM; Aboushleib HM; Bahey-El-Din M
    BMC Infect Dis; 2015 Mar; 15():147. PubMed ID: 25887456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human IgG1 and IgG3 recognition of Schistosoma mansoni 14kDa fatty acid-binding recombinant protein.
    Brito CF; Fonseca CT; Goes AM; Azevedo V; Simpson AJ; Oliveira SC
    Parasite Immunol; 2000 Jan; 22(1):41-8. PubMed ID: 10744504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. r-Sm14 - pRSETA efficacy in experimental animals.
    Ramos CR; Vilar MM; Nascimento AL; Ho PL; Thaumaturgo N; Edelenyi R; Almeida M; Dias WO; Diogo CM; Tendler M
    Mem Inst Oswaldo Cruz; 2001; 96 Suppl():131-5. PubMed ID: 11586438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary analysis of Sm14 in distinct fractions of Schistosoma mansoni adult worm extract.
    Thaumaturgo N; Vilar MM; Diogo CM; Edelenyi R; Tendler M
    Mem Inst Oswaldo Cruz; 2001; 96 Suppl():79-83. PubMed ID: 11586430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of immunization with recombinant Sm14 (rSm14) in reducing worm burden and mortality of mice infected with Schistosoma mansoni.
    Ribeiro F; Vieira Cdos S; Fernandes A; Araujo N; Katz N
    Rev Soc Bras Med Trop; 2002; 35(1):11-7. PubMed ID: 11873255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sm14 gene expression in different stages of the Schistosoma mansoni life cycle and immunolocalization of the Sm14 protein within the adult worm.
    Brito CF; Oliveira GC; Oliveira SC; Street M; Riengrojpitak S; Wilson RA; Simpson AJ; Correa-Oliveira R
    Braz J Med Biol Res; 2002 Mar; 35(3):377-81. PubMed ID: 11887217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice.
    Garcia TC; Fonseca CT; Pacifico LG; Durães Fdo V; Marinho FA; Penido ML; Caliari MV; de Melo AL; Pinto HA; Barsante MM; Cunha-Neto E; Oliveira SC
    Acta Trop; 2008 Jun; 106(3):162-7. PubMed ID: 18423420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase.
    Lee JJ; Sinha KA; Harrison JA; de Hormaeche RD; Riveau G; Pierce RJ; Capron A; Wilson RA; Khan CM
    Infect Immun; 2000 May; 68(5):2503-12. PubMed ID: 10768937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis.
    Norton PM; Brown HW; Wells JM; Macpherson AM; Wilson PW; Le Page RW
    FEMS Immunol Med Microbiol; 1996 Jun; 14(2-3):167-77. PubMed ID: 8809553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
    Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
    Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased immunogenicity and protection of recombinant Sm14 antigens by heat-killed Cutibacterium acnes in BALB/c mice infected with Schistosoma mansoni.
    Lam HYP; Huang SP; Liang TR; Wu WJ; Cheng PC; Chang KC; Peng SY
    Parasitol Int; 2022 Feb; 86():102446. PubMed ID: 34481947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.